<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR173">
 <label>173.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jakobovits</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Amado</surname>
    <given-names>RG</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Roskos</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Schwab</surname>
    <given-names>G</given-names>
   </name>
  </person-group>
  <article-title>From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice</article-title>
  <source>Nat Biotechnol</source>
  <year>2007</year>
  <volume>25</volume>
  <fpage>1134</fpage>
  <lpage>1143</lpage>
  <pub-id pub-id-type="doi">10.1038/nbt1337</pub-id>
  <?supplied-pmid 17921999?>
  <pub-id pub-id-type="pmid">17921999</pub-id>
 </element-citation>
</ref>
